Triple Immunotherapy Combos Enter The Ovarian Cancer Fight

Immunovaccine’s investigational cancer vaccine combined with an immunomodulator and a checkpoint inhibitor or other similar type of agent could have a synergistic beneficial effect on tumor cells, and lead to triple-drug combinations being evaluated in other cancers.

Supplement

More from Clinical Trials

More from R&D